Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trialBMJ 2000; 321 doi: http://dx.doi.org/10.1136/bmj.321.7252.13 (Published 01 July 2000) Cite this as: BMJ 2000;321:13
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial